221 related articles for article (PubMed ID: 31796056)
1. Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome.
Bucher-Johannessen C; Page CM; Haugen TB; Wojewodzic MW; Fosså SD; Grotmol T; Haugnes HS; Rounge TB
Clin Epigenetics; 2019 Dec; 11(1):179. PubMed ID: 31796056
[TBL] [Abstract][Full Text] [Related]
2. Genome- and epigenome-wide association studies identify susceptibility of CpG sites and regions for metabolic syndrome in a Korean population.
Lee HS; Kim B; Park T
Clin Epigenetics; 2024 Apr; 16(1):60. PubMed ID: 38685121
[TBL] [Abstract][Full Text] [Related]
3. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
Boer H; Westerink NL; Altena R; Nuver J; Dijck-Brouwer DAJ; van Faassen M; Klont F; Kema IP; Lefrandt JD; Zwart N; Boezen HM; Smit AJ; Meijer C; Gietema JA
Eur J Cancer; 2016 Feb; 54():104-111. PubMed ID: 26751392
[TBL] [Abstract][Full Text] [Related]
4. Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors.
Hjelle LV; Gundersen POM; Hellesnes R; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Bremnes RM; Haugnes HS
Acta Oncol; 2018 Oct; 57(10):1392-1400. PubMed ID: 29775128
[TBL] [Abstract][Full Text] [Related]
5. The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up.
Bjerring AW; Fosså SD; Haugnes HS; Nome R; Stokke TM; Haugaa KH; Kiserud CE; Edvardsen T; Sarvari SI
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):443-450. PubMed ID: 33152065
[TBL] [Abstract][Full Text] [Related]
6. Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivors.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Eur J Cancer; 2017 Oct; 84():9-17. PubMed ID: 28772110
[TBL] [Abstract][Full Text] [Related]
7. Methylation of SOCS3 is inversely associated with metabolic syndrome in an epigenome-wide association study of obesity.
Ali O; Cerjak D; Kent JW; James R; Blangero J; Carless MA; Zhang Y
Epigenetics; 2016 Sep; 11(9):699-707. PubMed ID: 27564309
[TBL] [Abstract][Full Text] [Related]
8. Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study.
Haugnes HS; Stenklev NC; Brydøy M; Dahl O; Wilsgaard T; Laukli E; Fosså SD
Acta Oncol; 2018 Aug; 57(8):1075-1083. PubMed ID: 29384420
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk in long-term survivors of testicular cancer.
Vaughn DJ; Palmer SC; Carver JR; Jacobs LA; Mohler ER
Cancer; 2008 May; 112(9):1949-53. PubMed ID: 18338810
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic age acceleration and metabolic syndrome in the coronary artery risk development in young adults study.
Nannini DR; Joyce BT; Zheng Y; Gao T; Liu L; Yoon G; Huan T; Ma J; Jacobs DR; Wilkins JT; Ren J; Zhang K; Khan SS; Allen NB; Horvath S; Lloyd-Jones DM; Greenland P; Hou L
Clin Epigenetics; 2019 Nov; 11(1):160. PubMed ID: 31730017
[TBL] [Abstract][Full Text] [Related]
11. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
[TBL] [Abstract][Full Text] [Related]
12. Sperm DNA methylome abnormalities occur both pre- and post-treatment in men with Hodgkin disease and testicular cancer.
Chan D; Oros Klein K; Riera-Escamilla A; Krausz C; O'Flaherty C; Chan P; Robaire B; Trasler JM
Clin Epigenetics; 2023 Jan; 15(1):5. PubMed ID: 36611168
[TBL] [Abstract][Full Text] [Related]
13. Abdominal visceral and subcutaneous fat increase, insulin resistance and hyperlipidemia in testicular cancer patients treated with cisplatin-based chemotherapy.
Willemse PM; van der Meer RW; Burggraaf J; van Elderen SG; de Kam ML; de Roos A; Lamb HJ; Osanto S
Acta Oncol; 2014 Mar; 53(3):351-60. PubMed ID: 23957624
[TBL] [Abstract][Full Text] [Related]
14. Long-term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin-based chemotherapy for malignant ovarian germ cell tumor.
Solheim O; Skalleberg J; Warncke T; Ørstavik K; Tropé C; Fosså SD
Acta Obstet Gynecol Scand; 2019 Feb; 98(2):240-249. PubMed ID: 30289161
[TBL] [Abstract][Full Text] [Related]
15. Race-specific alterations in DNA methylation among middle-aged African Americans and Whites with metabolic syndrome.
Chitrala KN; Hernandez DG; Nalls MA; Mode NA; Zonderman AB; Ezike N; Evans MK
Epigenetics; 2020 May; 15(5):462-482. PubMed ID: 31739726
[TBL] [Abstract][Full Text] [Related]
16. Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study.
Hellesnes R; Myklebust TÅ; Bremnes RM; Karlsdottir Á; Kvammen Ø; Negaard HFS; Tandstad T; Wilsgaard T; Fosså SD; Haugnes HS
J Clin Oncol; 2021 Feb; 39(4):308-318. PubMed ID: 33356420
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors.
Willemse PM; Burggraaf J; Hamdy NA; Weijl NI; Vossen CY; van Wulften L; van Steijn-van Tol AQ; Rosendaal FR; Osanto S
Br J Cancer; 2013 Jul; 109(1):60-7. PubMed ID: 23660945
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic alterations in sperm DNA associated with testicular cancer treatment.
Chan D; Delbès G; Landry M; Robaire B; Trasler JM
Toxicol Sci; 2012 Feb; 125(2):532-43. PubMed ID: 22076425
[TBL] [Abstract][Full Text] [Related]
19. Early development of the metabolic syndrome after chemotherapy for testicular cancer.
de Haas EC; Altena R; Boezen HM; Zwart N; Smit AJ; Bakker SJ; van Roon AM; Postma A; Wolffenbuttel BH; Hoekstra HJ; van Leeuwen FE; Sleijfer DT; Gietema JA
Ann Oncol; 2013 Mar; 24(3):749-55. PubMed ID: 23131388
[TBL] [Abstract][Full Text] [Related]
20. Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatment.
Krushkal J; Zhao Y; Hose C; Monks A; Doroshow JH; Simon R
Clin Epigenetics; 2016; 8():73. PubMed ID: 27347216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
